esomeprazole 40 mg

ApprovedCompleted
0 watching 0 views this week๐Ÿ”ฅ Hot
85
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
โœ“
Phase 3
5
Approved
Indication / Disease

Heartburn

Conditions

Heartburn

Trial Timeline

Nov 1, 2010 โ†’ Jun 1, 2011

About esomeprazole 40 mg

esomeprazole 40 mg is a approved stage product being developed by AstraZeneca for Heartburn. The current trial status is completed. This product is registered under clinical trial identifier NCT01249651. Target conditions include Heartburn.

Hype Score Breakdown

Clinical
30
Activity
20
Company
10
Novelty
10
Community
12

Clinical Trials (2)

NCT IDPhaseStatus
NCT01249651ApprovedCompleted
NCT00734097ApprovedCompleted